Conviction
1 → 3
Conviction●●●○○3 of 5
Research target$200.67Snapshot target
Thesis statusINTACTLast reviewed 7/8/26
Market cap$11.39BSnapshot value
Research history
See all PODD changes ↗What changed
Target
— → $200.67
Thesis status
NEEDS_MORE_DATA → INTACT
Last reviewed
Not reviewed → 7/8/26
Target
— → $200.67
Continuous insulin delivery: Omnipod automated insulin delivery integrating with CGM. Razor-blade model — Pod recurring revenue per patient.
Automated insulin delivery adoption; CGM integration driving Pod demand; Type 2 diabetes expansion; pediatric adoption.
Competitive pressure from Medtronic/Tandem; reimbursement concentration; GLP-1 reducing insulin-dependent diabetes prevalence long-term.
needs X/Reddit sentiment sweep
Snapshot · 7/8/26🟢 Confirmed · ins+$0.9M(2buy👥) · 13F 13+/12- · short↑0.33
Snapshot · 7/8/26